Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity.
about
Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cellsRho GTPase-dependent signaling is required for macrophage migration inhibitory factor-mediated expression of cyclin D1.Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma.Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repairMass Spectrometric Immunoassay for the qualitative and quantitative analysis of the cytokine Macrophage Migration Inhibitory Factor (MIF)P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell MDA-MB-231 contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment.PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancerGenomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.Stromal-dependent tumor promotion by MIF family members.Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomasTumor angiogenesis of non-small cell lung cancer.MIF family members cooperatively inhibit p53 expression and activityDiversity of the angiogenic phenotype in non-small cell lung cancer.25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor Angiogenesis.Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model.Function of PPARgamma and its ligands in lung cancer.Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer.CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.PPAR Agonists for the Prevention and Treatment of Lung Cancer.Immune alterations and emerging immunotherapeutic approaches in lung cancer.Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.Dissociation of MIF-rpS3 complex and sequential NF-κB activation is involved in IR-induced metastatic conversion of NSCLC.Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells.Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.Interaction of monocytes/macrophages with ovarian cancer cells promotes angiogenesis in vitro.Nanomedicine Strategies to Target Tumor-Associated Macrophages.Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells.Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor.Inhibition of lymphokine-activated killer cells generation in vitro by soluble factors released from mixed human tumor and peripheral blood mononuclear adherent cells culture.Breast tumor cell soluble factors induce monocytes to produce angiogenic but not angiostatic CXC chemokines.Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma.A novel pathway for nickel-induced interleukin-8 expression.Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo.Induced interleukin-8 expression in gliomas by tumor-associated macrophages.
P2860
Q28218473-942BF528-B4D0-49AC-98F3-82F4CFDF5743Q30448193-D678DB3B-26BA-4047-B307-6EC1B3DC4C88Q31045877-F6CA82AE-B0FE-46AA-B5CD-C786C119A5D5Q34268934-8766378C-F6B5-4970-B276-DEB89B7C7BF4Q34362934-CFA82BE4-AC6B-4775-811F-DB32B606BF71Q34619350-998C189F-9DB8-451F-9B72-857FC7FDE496Q34768343-06CAE1E6-37E1-45C3-A6D7-D14DE12B1575Q34928581-A50A3870-DE37-4ED2-BEE2-CB71189225F4Q34944820-B450B886-8917-40F0-B755-070655D58B4FQ35045522-21A6DA25-43FC-4F68-B01D-0248FB91B317Q35050045-56755ED9-0535-4A6E-934B-7B968F81EBECQ35188786-917A21DD-2AC4-4CA6-8A0D-2DE3FCBB4870Q35855285-55973C5E-76F5-4C89-A1E5-326BBFF36D7DQ36322394-7196B642-36CE-4A8B-AD3B-189F76A73628Q36385260-27577813-2829-4E39-A413-B01E939B820EQ36414175-F5DDB3C4-F8EE-414C-AAB4-A01AE8782512Q37071916-C77B9680-051F-4731-B2E4-E8B8257EBD45Q37529430-DA1DA459-6DA6-4BF8-A92C-8D10BA5D2572Q37681630-EC800748-0C50-45CD-87EE-CAE2FB42A17CQ38007549-406C0573-484F-4E7F-9B11-272BA7741123Q38283244-F0DE8601-CCF1-4D8D-B782-8137205843CCQ38883785-6F254509-A9D2-45AF-844F-8E42455109D4Q39147966-3C3F2BE0-8352-4361-85E3-5937EA56CCD4Q39177042-9325B348-8F5C-42ED-B4BB-ECF59489AE1EQ39198190-8AC4E7CA-9870-46AE-89AE-0E762706A1F8Q39205417-141E8B1F-D8F8-4B7E-8A54-7F479C0C0FB6Q39283111-9ADB6DC9-AE61-4110-A23F-1963E819A76AQ39481195-7DAF9EE0-190E-45F3-A42E-CAA56ED8CF6AQ39953292-2358AC53-4621-41D5-9839-85A6055C61D3Q40091422-5E2C5BBD-AF58-438A-9198-DD34C7422697Q40318967-01AD9712-89B8-4382-AF15-20F516A80E89Q40462497-62D13702-C037-4796-AC23-5200C72FB50DQ40491558-697694EF-2D07-4960-9C9B-DBC1C62608A3Q40735514-595B5465-15F2-4589-A251-B09E8AAD5E80Q42940126-C5405B08-C7D6-46C3-812E-FD31A2BD65B8Q46155426-52946439-5BC9-4A9C-B7AA-6A7E37D1E200
P2860
Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Non-small cell lung cancer cel ...... ession of angiogenic activity.
@en
type
label
Non-small cell lung cancer cel ...... ession of angiogenic activity.
@en
prefLabel
Non-small cell lung cancer cel ...... ession of angiogenic activity.
@en
P2093
P1476
Non-small cell lung cancer cel ...... ession of angiogenic activity.
@en
P2093
P304
P356
10.4049/JIMMUNOL.166.12.7549
P407
P577
2001-06-01T00:00:00Z